CYP26C1

cytochrome P450 family 26 subfamily C member 1, the group of Cytochrome P450 family 26

Basic information

Region (hg38): 10:93060798-93069540

Links

ENSG00000187553NCBI:340665OMIM:608428HGNC:20577Uniprot:Q6V0L0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • focal facial dermal dysplasia type IV (Limited), mode of inheritance: AR
  • focal facial dermal dysplasia type IV (Supportive), mode of inheritance: AR
  • focal facial dermal dysplasia type IV (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Focal facial dermal dysplasia 4ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Dermatologic16530710; 23161670

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CYP26C1 gene.

  • not_specified (82 variants)
  • not_provided (18 variants)
  • CYP26C1-related_disorder (7 variants)
  • Focal_facial_dermal_dysplasia_type_IV (3 variants)
  • Optic_nerve_hypoplasia (2 variants)
  • Anophthalmia-microphthalmia_syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP26C1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000183374.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
9
clinvar
3
clinvar
12
missense
1
clinvar
80
clinvar
5
clinvar
3
clinvar
89
nonsense
0
start loss
0
frameshift
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total 1 2 81 14 6

Highest pathogenic variant AF is 0.0005741553

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CYP26C1protein_codingprotein_codingENST00000285949 67434
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.001640.97412515015651257160.00225
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.05852742770.9900.00001363219
Missense in Polyphen120117.651.01991409
Synonymous1.541091320.8290.000006681181
Loss of Function1.97715.30.4577.17e-7170

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007660.000765
Ashkenazi Jewish0.000.00
East Asian0.001210.00109
Finnish0.007160.00719
European (Non-Finnish)0.003200.00317
Middle Eastern0.001210.00109
South Asian0.00003280.0000327
Other0.002310.00229

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role in retinoic acid metabolism. Acts on retinoids, including all-trans-retinoic acid (RA) and its stereoisomer 9-cis-RA (preferred substrate).;
Disease
DISEASE: Focal facial dermal dysplasia 4 (FFDD4) [MIM:614974]: A form of focal facial dermal dysplasia, a group of developmental defects characterized by bitemporal or preauricular skin lesions resembling aplasia cutis congenita. Skin defects occur at the sites of facial fusion during embryogenesis, with temporal lesions situated at the junction between the frontonasal and maxillary facial prominences, and preauricular lesions at the meeting point of the maxillary and mandibular prominences. The ectodermal lesions show consistent histologic abnormalities: atrophy and flattening of the epidermis, replacement of the dermis by loose connective tissue, reduced levels of fragmented elastic tissue and absence of the subcutaneous tissues and adnexal structures. FFDD4 is characterized by isolated, preauricular skin lesions. {ECO:0000269|PubMed:23161670}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Retinol metabolism - Homo sapiens (human);Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II;Signal Transduction;Phase I - Functionalization of compounds;RA biosynthesis pathway;Vitamins;Cytochrome P450 - arranged by substrate type;Biological oxidations;Metabolism;Signaling by Retinoic Acid;Signaling by Nuclear Receptors (Consensus)

Haploinsufficiency Scores

pHI
0.224
hipred
Y
hipred_score
0.589
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.281

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cyp26c1
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; craniofacial phenotype; growth/size/body region phenotype; cellular phenotype;

Zebrafish Information Network

Gene name
cyp26c1
Affected structure
pharyngeal arch
Phenotype tag
abnormal
Phenotype quality
morphology

Gene ontology

Biological process
vitamin metabolic process;central nervous system development;anterior/posterior pattern specification;neural crest cell development;sterol metabolic process;retinoic acid catabolic process;organelle fusion;negative regulation of retinoic acid receptor signaling pathway;oxidation-reduction process
Cellular component
endoplasmic reticulum membrane;integral component of membrane
Molecular function
retinoic acid binding;iron ion binding;retinoic acid 4-hydroxylase activity;heme binding